The endocrine system is a group of glands that create and release hormones to control important bodily functions, such as metabolism, growth, reproduction etc. The endocrine system plays a vital role in prevention of several chronic and metabolic diseases. Generally, endocrine disorders are divided into two categories: diseases resulting when the glands over-produce or under-produce (hormone imbalance) and diseases sue to development of lesions in the endocrine system.

The purpose of this research study titled ‘Endocrine Testing Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global endocrine testing market. This report presents and analyzes the major trends prevalent in the global endocrine testing market and the market size and forecast.

This report categorizes the global endocrine testing market in terms of test type, endocrine disorder, testing technology, end-users and geographical distribution. For the purpose of this study, the test types considered include estradiol (E2) testing, follicle stimulating hormone (FSH) testing, human chorionic gonadotropin (hCG) hormone testing, luteinizing hormone (LH) testing, dehydroepiandrosterone sulfate (DHEAS) testing, progesterone testing, testosterone testing, thyroid stimulating hormone (TSH) testing, prolactin testing, cortisol testing, insulin testing and others. The endocrine disorders studied in this report are categorized as adrenal disorders, calcium problems, glucose (islet cells) disorders, male and female gonadal problems, hypertensive and heart disorders, thyroid disorders and pituitary disorders.

Based on testing technologies, the global endocrine testing market is studied for immunoassay technology, tandem mass spectrometry, sensors technology, monoclonal and polyclonal antibody technology, clinical chemistry technology and others. This report also categorizes the global endocrine testing market by end-users such as hospitals, clinical laboratories, research and academia, and others. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional analysis is presented in terms of test type, endocrine disorder, testing technology, end-users and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global endocrine testing market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the endocrine testing market. The key players profiled in this report are Abbott Laboratories, AB Sciex Pte Ltd., Agilent Technologies, Inc., Biomedical Technologies (Alfa Aesar), bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Ortho-clinical Diagnostics, Quest Technology Pte Ltd., Sysmex Corporation and Teleflex Incorporated.

Diabetes is among the most prominent areas where endocrine testing is widely used. As the global prevalence of diabetes is on perpetual rise, it is also opined that there is still a huge population of undiagnosed patients. People can have prediabetes or type 2 diabetes for several years without exhibiting distinguishable symptoms. As a matter of fact, type 2 diabetes often goes undiagnosed until the related complications appear. Such complications include renal disease, vision impairment and even nerve damage. If not diagnosed in time, and left untreated, diabetes can result in several complications and eventual mortality. Efficient and accurate diagnosis of diabetes is very critical to make the needed lifestyle changes or take medications for disease management. It is often recommended to perform diabetes screening in people with high risk of developing diabetes.

Among the considered test types, thyroid stimulating hormone testing and insulin testing together will capture the largest market share throughout the forecast period 2017-2025. Thyroid function disorders are common worldwide and screening and diagnosis forms a critical part of disease management. Symptoms of thyroid disorders are extremely prevalent in general population and are non-specific. Increasing information available too general public has let to voluntary testing by patients worldwide. TSH, T4 and anti-TPO antibodies are the three most important biochemical tests for assessing thyroid function. Of these, the TSH testing assay is the most reliable test for diagnosis of primary hypo- and hyperthyroidism, where the first generation TSH testing can only diagnose hypothyroidism.

Growing prevalence of metabolic disorders, sexual dysfunction, diabetes, renal diseases and obesity has led to emergence of heightened demand for endocrine testing methods. Regular monitoring of endocrine hormones play a critical role in the management of diabetes and related complications across all demographics. There is also an increasing significance of obesity as co-morbidity in the growing prevalence of disorders of the reproductive system, strokes, cardiovascular diseases and cancer. This increase in the patient pool is expected to favor the growth of endocrine testing market. However, high costs of novel testing technologies may restrain widespread acceptance of novel tests, especially in developing countries. Among the currently available testing technologies, immunoassay technology is the largest revenue generating segment and it is anticipated that the trend shall continue during the forecast period. Technologies such as tandem mass spectrometry will witness significant traction through the forecast period as a result of their proven precision and accuracy in result delivery.

Geographically, the global endocrine testing market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
 

North America (U.S. and Canada) is the clear leader in the global endocrine testing market, followed by Europe. Significant prevalence of obesity, chronic endocrine disorders such as diabetes and thyroid diseases, and reproductive health disorders are the key factors contributing to the dominance of North America market. Furthermore, supportive government regulations facilitating swift adoption of novel testing technologies and evolved reimbursement scenario additionally drive the North America endocrine testing market. On the other hand, huge population base and rising incidence of lifestyle-related diseases has led to the emergence of Asia Pacific as the fastest progressing regional market for endocrine testing.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Endocrine Testing market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Endocrine Testing market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Endocrine Testing market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Endocrine Testing market?
• Which is the largest regional market for Endocrine Testing market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Endocrine Testing market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Endocrine Testing market worldwide?